Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Cellbxhealth (CLBX) Share Price

Price 1.725p on 27-05-2026 at 14:21:23
Change 0.10p 6.15%
Buy 1.80p
Sell 1.65p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 150,000.00 at 1.75p
Day's Volume: 4,567,544
Last Close: 1.625p
Open: 1.625p
ISIN: GB0034330679
Day's Range 1.625p - 1.75p
52wk Range: 0.85p - 8.10p
Market Capitalisation: £33.59m
VWAP: 1.72124p
Shares in Issue: 1.95b

Cellbxhealth (CLBX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 150,000 1.75p Ordinary
 15:21:19 - 27-May-26
Buy* 10,000 1.78p Ordinary
 15:20:12 - 27-May-26
Buy* 122,905 1.79p Ordinary
 15:08:47 - 27-May-26
Sell* 23,000 1.702p Ordinary
 15:07:32 - 27-May-26
Buy* 2,793 1.79p Ordinary
 15:05:10 - 27-May-26
Sell* 120,900 1.699p Ordinary
 14:20:53 - 27-May-26
Buy* 28,024 1.77p Ordinary
 14:11:13 - 27-May-26
Buy* 288 1.77p Ordinary
 14:10:47 - 27-May-26
Buy* 28,027 1.77p Ordinary
 14:00:42 - 27-May-26
Buy* 112,994 1.77p Ordinary
 13:55:57 - 27-May-26
See more Cellbxhealth trades

Cellbxhealth (CLBX) Share Price History

Time period:
to
Date Open High Low Close Volume
26th May 2026 (Tue) 1.75 1.925 1.60 1.625 15,639,757
25th May 2026 (Mon) 1.75 1.75 1.75 1.75 0
22nd May 2026 (Fri) 1.40 1.90 1.40 1.75 41,227,378
21st May 2026 (Thu) 1.25 1.45 1.25 1.40 25,005,514
20th May 2026 (Wed) 1.15 1.25 1.15 1.25 6,167,286
19th May 2026 (Tue) 1.075 1.15 1.075 1.15 2,893,759
18th May 2026 (Mon) 1.10 1.075 1.00 1.075 6,840,285
15th May 2026 (Fri) 1.075 1.10 1.075 1.10 2,853,175
14th May 2026 (Thu) 1.10 1.075 1.05 1.075 3,207,405
13th May 2026 (Wed) 1.125 1.15 1.075 1.10 5,064,342
12th May 2026 (Tue) 1.25 1.25 1.075 1.125 13,884,643
11th May 2026 (Mon) 1.05 1.35 1.05 1.25 42,445,308
8th May 2026 (Fri) 0.875 1.125 0.875 1.025 28,826,601
7th May 2026 (Thu) 0.85 0.875 0.85 0.875 925,017
6th May 2026 (Wed) 0.90 0.90 0.85 0.85 1,551,072
5th May 2026 (Tue) 0.90 0.90 0.90 0.90 735,161
4th May 2026 (Mon) 0.90 0.90 0.90 0.90 0
1st May 2026 (Fri) 0.90 0.90 0.90 0.90 1,582,939
30th Apr 2026 (Thu) 0.925 0.925 0.90 0.90 7,249,074
29th Apr 2026 (Wed) 0.925 0.95 0.925 0.925 5,334,580
28th Apr 2026 (Tue) 0.95 0.90 0.90 0.90 647,832
27th Apr 2026 (Mon) 0.975 0.975 0.95 0.95 1,704,571
See more Cellbxhealth price history

Cellbxhealth (CLBX) Regulatory News

Date Source Headline
18th May 2026 7:00 am RNS Collaboration with AdventHealth for two studies
11th May 2026 7:00 am RNS Q1 trading update and outlook for 2026
30th Apr 2026 7:00 am RNS Confirmation of Q1 trading update
20th Apr 2026 7:00 am RNS Research Collaboration with The Royal Marsden
16th Apr 2026 5:39 pm RNS Board changes - Replacement
13th Feb 2026 7:00 am RNS Aligning Regulatory Approach with Commercial Needs
16th Jan 2026 7:00 am RNS Preliminary Fourth Quarter 2025 Financial Results
12th Jan 2026 7:00 am RNS Board changes
23rd Dec 2025 9:15 am RNS Holding(s) in Company
23rd Dec 2025 9:15 am RNS Holding(s) in Company
See more Cellbxhealth regulatory news

Cellbxhealth (CLBX) Share News

WINNERS & LOSERS: Creo Medical jumps; Hercules resumes trading

22nd May 2026 09:37

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday. Read More

CelLBxHealth shares jump on forecast for 50% revenue growth in 2026

11th May 2026 13:42

(Alliance News) - CelLBxHealth PLC on Monday said it expects at least 50% revenue growth in 2026 as it advances its turnaround strategy and continues to reduce costs. Read More

WINNERS & LOSERS: Asos sells Lichfield centre; CelLBxHealth revenue up

11th May 2026 11:24

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More

LONDON BRIEFING: Compass lifts outlook as GSK expands in China

11th May 2026 07:56

(Alliance News) - Compass Group raised annual profit guidance after reporting double-digit first-half operating profit growth, while GSK announced a China partnership for hepatitis B treatment bepirovirsen and the final tranche of its GBP2 billion buyback. Elsewhere, Victrex warned higher energy costs linked to the Middle East conflict could weigh on demand as interim profit declined. Read More

TRADING UPDATES: Metir distribution deals in Middle East, Africa, Asia

20th Apr 2026 18:29

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

See more Cellbxhealth news
FTSE 100 Latest
Value10,468.65
Change-22.74

Login to your account

Forgot Password?

Not Registered